Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability of MK-4618 when coadministered with
antihypertensive agents and will evaluate changes in blood pressure following
co-administration of MK-4618 with a beta blocker and a vasodilator. The primary hypothesis of
the study is that MK-4618 does not result in a clinically meaningful change in systolic blood
pressure relative to placebo when co-administered with a beta-blocker or with amlodipine.